Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Viridian Therapeutics, Inc.\DE (VRDN) Interest Coverage Ratio: 2014-2025

Historic Interest Coverage Ratio for Viridian Therapeutics, Inc.\DE (VRDN) over the last 11 years, with Sep 2025 value amounting to -71.45.

  • Viridian Therapeutics, Inc.\DE's Interest Coverage Ratio rose 54.72% to -71.45 in Q3 2025 from the same period last year, while for Sep 2025 it was -108.43, marking a year-over-year decrease of 0.72%. This contributed to the annual value of -98.17 for FY2024, which is 28.74% up from last year.
  • As of Q3 2025, Viridian Therapeutics, Inc.\DE's Interest Coverage Ratio stood at -71.45, which was up 65.60% from -207.72 recorded in Q2 2025.
  • In the past 5 years, Viridian Therapeutics, Inc.\DE's Interest Coverage Ratio registered a high of -64.04 during Q4 2024, and its lowest value of -9,693.67 during Q4 2021.
  • In the last 3 years, Viridian Therapeutics, Inc.\DE's Interest Coverage Ratio had a median value of -120.92 in 2024 and averaged -167.00.
  • As far as peak fluctuations go, Viridian Therapeutics, Inc.\DE's Interest Coverage Ratio tumbled by 1,825.94% in 2021, and later surged by 96.99% in 2022.
  • Over the past 5 years, Viridian Therapeutics, Inc.\DE's Interest Coverage Ratio (Quarterly) stood at -9,693.67 in 2021, then soared by 96.99% to -292.06 in 2022, then soared by 73.28% to -78.03 in 2023, then climbed by 17.94% to -64.04 in 2024, then skyrocketed by 54.72% to -71.45 in 2025.
  • Its last three reported values are -71.45 in Q3 2025, -207.72 for Q2 2025, and -160.18 during Q1 2025.